+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

3D Printed Drugs Market Research Report by Technology (Direct-Write, Fused Deposition Modelling, and Inkjet Printing), End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4857884
  • Report
  • April 2022
  • Region: Global
  • 208 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • 3D Systems, Inc.
  • BioDuro, LLC
  • EnvisionTEC GmbH
  • General Electric Company
  • Merck KGaA
  • Siemens AG
The Global 3D Printed Drugs Market size was estimated at USD 175.19 million in 2020, USD 191.70 million in 2021, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 10.46% to reach USD 318.36 million by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the 3D Printed Drugs to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Technology, the market was studied across Direct-Write, Fused Deposition Modelling, Inkjet Printing, Powder Bed Printing, Stereolithography, and Zip Dose.
  • Based on End User, the market was studied across Clinics & Hospitals and Research Laboratories.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the 3D Printed Drugs Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global 3D Printed Drugs Market, including 3D Systems, Inc., Anatomics Pty Ltd, Aprecia Pharmaceuticals, LLC, BioDuro, LLC, Biomedical Modeling Inc., EnvisionTEC GmbH, FabRx Ltd., General Electric Company, Materialise NV, Merck KGaA, Renishaw PLC, Siemens AG, Stratasys Ltd., Triastek, Inc., Yissum, and Zortrax S.A..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global 3D Printed Drugs Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global 3D Printed Drugs Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global 3D Printed Drugs Market?
4. What is the competitive strategic window for opportunities in the Global 3D Printed Drugs Market?
5. What are the technology trends and regulatory frameworks in the Global 3D Printed Drugs Market?
6. What is the market share of the leading vendors in the Global 3D Printed Drugs Market?
7. What modes and strategic moves are considered suitable for entering the Global 3D Printed Drugs Market?
Frequently Asked Questions about the Global 3D Printed Drugs Market

What is the estimated value of the Global 3D Printed Drugs Market?

The Global 3D Printed Drugs Market was estimated to be valued at $175.2 Million in 2020.

What is the growth rate of the Global 3D Printed Drugs Market?

The growth rate of the Global 3D Printed Drugs Market is 10.4%, with an estimated value of $318.4 Million by 2026.

What is the forecasted size of the Global 3D Printed Drugs Market?

The Global 3D Printed Drugs Market is estimated to be worth $318.4 Million by 2026.

Who are the key companies in the Global 3D Printed Drugs Market?

Key companies in the Global 3D Printed Drugs Market include 3D Systems, Inc., Anatomics Pty Ltd, Aprecia Pharmaceuticals, LLC, BioDuro, LLC, Biomedical Modeling Inc., EnvisionTEC GmbH, FabRx Ltd., General Electric Company and Merck KGaA.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 3D Systems, Inc.
  • BioDuro, LLC
  • EnvisionTEC GmbH
  • General Electric Company
  • Merck KGaA
  • Siemens AG

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Surge in Demand for Instantaneous Soluble Drugs
5.1.1.2. Increasing use of 3D Printing Technique in the Medical & Healthcare Industries
5.1.1.3. Growing Adoption of Personalized Drugs and Production of the Combination Medicine
5.1.2. Restraints
5.1.2.1. Antagonistic Effects Related to Drugs
5.1.2.2. Usage of 3D Printing to Develop Illegal Drugs
5.1.3. Opportunities
5.1.3.1. Constant Technological Developments in 3D Printing Technique
5.1.3.2. Growth Potential in Developing Countries with the Introduction of 3D Printed Drugs
5.1.3.3. Rise in Health Care Investment in Emerging Countries
5.1.4. Challenges
5.1.4.1. Lack of Government Regulations for 3D Printed Products
5.2. Cumulative Impact of COVID-19
6. 3D Printed Drugs Market, by Technology
6.1. Introduction
6.2. Direct-Write
6.3. Fused Deposition Modelling
6.4. Inkjet Printing
6.5. Powder Bed Printing
6.6. Stereolithography
6.7. Zip Dose
7. 3D Printed Drugs Market, by End User
7.1. Introduction
7.2. Clinics & Hospitals
7.3. Research Laboratories
8. Americas 3D Printed Drugs Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific 3D Printed Drugs Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
10. Europe, Middle East & Africa 3D Printed Drugs Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. 3D Systems, Inc.
12.2. Anatomics Pty Ltd
12.3. Aprecia Pharmaceuticals, LLC
12.4. BioDuro, LLC
12.5. Biomedical Modeling Inc.
12.6. EnvisionTEC GmbH
12.7. FabRx Ltd.
12.8. General Electric Company
12.9. Materialise NV
12.10. Merck KGaA
12.11. Renishaw PLC
12.12. Siemens AG
12.13. Stratasys Ltd.
12.14. Triastek, Inc.
12.15. Yissum
12.16. Zortrax S.A.
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL 3D PRINTED DRUGS MARKET: DYNAMICS
FIGURE 2. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2020 VS 2026 (%)
FIGURE 3. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2020 VS 2026 (USD MILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2026
FIGURE 5. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DIRECT-WRITE, 2018-2026 (USD MILLION)
FIGURE 6. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DIRECT-WRITE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 7. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELLING, 2018-2026 (USD MILLION)
FIGURE 8. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELLING, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 9. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, 2018-2026 (USD MILLION)
FIGURE 10. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 11. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY POWDER BED PRINTING, 2018-2026 (USD MILLION)
FIGURE 12. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY POWDER BED PRINTING, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 13. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, 2018-2026 (USD MILLION)
FIGURE 14. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 15. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY ZIP DOSE, 2018-2026 (USD MILLION)
FIGURE 16. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY ZIP DOSE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 17. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2020 VS 2026 (%)
FIGURE 18. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
FIGURE 19. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2026
FIGURE 20. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY CLINICS & HOSPITALS, 2018-2026 (USD MILLION)
FIGURE 21. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY CLINICS & HOSPITALS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 22. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2026 (USD MILLION)
FIGURE 23. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 24. AMERICAS 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 25. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 26. BRAZIL 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 27. CANADA 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 28. MEXICO 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 29. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 30. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 31. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 32. CHINA 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 33. INDIA 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 34. INDONESIA 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 35. JAPAN 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 36. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 37. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 38. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 39. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 40. TAIWAN 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 41. THAILAND 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 42. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 43. FRANCE 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 44. GERMANY 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 45. ITALY 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 46. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 47. QATAR 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 48. RUSSIA 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 49. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 50. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 51. SPAIN 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 52. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 53. UNITED KINGDOM 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 54. GLOBAL 3D PRINTED DRUGS MARKET: FPNV POSITIONING MATRIX
FIGURE 55. GLOBAL 3D PRINTED DRUGS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 56. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL 3D PRINTED DRUGS MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL 3D PRINTED DRUGS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY DIRECT-WRITE, BY REGION, 2018-2026 (USD MILLION)
TABLE 5. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY DIRECT-WRITE, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 6. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY DIRECT-WRITE, BY STATE, 2018-2026 (USD MILLION)
TABLE 7. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY DIRECT-WRITE, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY DIRECT-WRITE, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELLING, BY REGION, 2018-2026 (USD MILLION)
TABLE 10. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELLING, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 11. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELLING, BY STATE, 2018-2026 (USD MILLION)
TABLE 12. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELLING, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY FUSED DEPOSITION MODELLING, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 14. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, BY REGION, 2018-2026 (USD MILLION)
TABLE 15. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 16. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, BY STATE, 2018-2026 (USD MILLION)
TABLE 17. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 18. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY INKJET PRINTING, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 19. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY POWDER BED PRINTING, BY REGION, 2018-2026 (USD MILLION)
TABLE 20. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY POWDER BED PRINTING, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 21. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY POWDER BED PRINTING, BY STATE, 2018-2026 (USD MILLION)
TABLE 22. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY POWDER BED PRINTING, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 23. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY POWDER BED PRINTING, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 24. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, BY REGION, 2018-2026 (USD MILLION)
TABLE 25. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 26. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, BY STATE, 2018-2026 (USD MILLION)
TABLE 27. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 28. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY STEREOLITHOGRAPHY, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 29. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY ZIP DOSE, BY REGION, 2018-2026 (USD MILLION)
TABLE 30. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY ZIP DOSE, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 31. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY ZIP DOSE, BY STATE, 2018-2026 (USD MILLION)
TABLE 32. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY ZIP DOSE, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 33. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY ZIP DOSE, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 34. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 35. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY CLINICS & HOSPITALS, BY REGION, 2018-2026 (USD MILLION)
TABLE 36. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY CLINICS & HOSPITALS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 37. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY CLINICS & HOSPITALS, BY STATE, 2018-2026 (USD MILLION)
TABLE 38. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY CLINICS & HOSPITALS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 39. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY CLINICS & HOSPITALS, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 40. GLOBAL 3D PRINTED DRUGS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2026 (USD MILLION)
TABLE 41. AMERICAS 3D PRINTED DRUGS MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 42. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, BY RESEARCH LABORATORIES, BY STATE, 2018-2026 (USD MILLION)
TABLE 43. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 44. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2018-2026 (USD MILLION)
TABLE 45. AMERICAS 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 46. ARGENTINA 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 47. BRAZIL 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 48. CANADA 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 49. MEXICO 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 50. UNITED STATES 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 51. ASIA-PACIFIC 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 52. AUSTRALIA 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 53. CHINA 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 54. INDIA 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 55. INDONESIA 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 56. JAPAN 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 57. MALAYSIA 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 58. PHILIPPINES 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 59. SINGAPORE 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 60. SOUTH KOREA 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 61. TAIWAN 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 62. THAILAND 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 63. EUROPE, MIDDLE EAST & AFRICA 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 64. FRANCE 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 65. GERMANY 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 66. ITALY 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 67. NETHERLANDS 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 68. QATAR 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 69. RUSSIA 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 70. SAUDI ARABIA 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 71. SOUTH AFRICA 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 72. SPAIN 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 73. UNITED ARAB EMIRATES 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 74. UNITED KINGDOM 3D PRINTED DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 75. GLOBAL 3D PRINTED DRUGS MARKET: SCORES
TABLE 76. GLOBAL 3D PRINTED DRUGS MARKET: BUSINESS STRATEGY
TABLE 77. GLOBAL 3D PRINTED DRUGS MARKET: PRODUCT SATISFACTION
TABLE 78. GLOBAL 3D PRINTED DRUGS MARKET: RANKING
TABLE 79. GLOBAL 3D PRINTED DRUGS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 80. GLOBAL 3D PRINTED DRUGS MARKET: MERGER & ACQUISITION
TABLE 81. GLOBAL 3D PRINTED DRUGS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 82. GLOBAL 3D PRINTED DRUGS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 83. GLOBAL 3D PRINTED DRUGS MARKET: INVESTMENT & FUNDING
TABLE 84. GLOBAL 3D PRINTED DRUGS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 85. GLOBAL 3D PRINTED DRUGS MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • 3D Systems, Inc.
  • Anatomics Pty Ltd
  • Aprecia Pharmaceuticals, LLC
  • BioDuro, LLC
  • Biomedical Modeling Inc.
  • EnvisionTEC GmbH
  • FabRx Ltd.
  • General Electric Company
  • Materialise NV
  • Merck KGaA
  • Renishaw PLC
  • Siemens AG
  • Stratasys Ltd.
  • Triastek, Inc.
  • Yissum
  • Zortrax S.A.
Note: Product cover images may vary from those shown

Loading
LOADING...